2011
DOI: 10.1007/s10517-011-1284-1
|View full text |Cite
|
Sign up to set email alerts
|

Correction of Endothelial Dysfunction in Patients with Arterial Hypertension

Abstract: We examined 38 patients (mean age 55.92 ± 1.56 years) with a 3-5-year history of arterial hypertension. The study showed that hypertension is accompanied by endothelial dysfunction and one of its forming factors is activation of the inflammatory response. Highly sensitive diagnostic tests can verify initiation of inflammation in preclinical manifestations. The use of nonsteroidal anti-inflammatory drugs, irrespective of the tropism to cyclooxygenase forms, alleviates manifestations of endothelial dysfunction i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
9
0
2

Year Published

2013
2013
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 3 publications
0
9
0
2
Order By: Relevance
“…Another study, with similar aspirin dosing and duration of treatment, showed improvement in flow-mediated dilation and decrease in C-reactive protein and intercellular adhesion molecules level with aspirin. However, due to the study design, it was impossible to reliably separate effects of aspirin from effects of concomitant treatments [89]. In another study, aspirin therapy resulted in improvement of flow-mediated dilation and blood pressure reduction, when combined with statins, while no significant dynamics was observed on aspirin monotherapy [90].…”
Section: Introductionmentioning
confidence: 99%
“…Another study, with similar aspirin dosing and duration of treatment, showed improvement in flow-mediated dilation and decrease in C-reactive protein and intercellular adhesion molecules level with aspirin. However, due to the study design, it was impossible to reliably separate effects of aspirin from effects of concomitant treatments [89]. In another study, aspirin therapy resulted in improvement of flow-mediated dilation and blood pressure reduction, when combined with statins, while no significant dynamics was observed on aspirin monotherapy [90].…”
Section: Introductionmentioning
confidence: 99%
“…1: mais importante a condição funcional que idade cronológica; 2: incluindo fragilidade leve; 3: fragilidade moderada a severa; 4: incluindo idosos com comorbidades: DM, DAC, DRC, ACV/EIT (não se refere à fase aguda); 5: avaliar ativamente a tolerabilidade, inclusive possíveis sintomas atípicos; 6: umna meta mais rígida(125)(126)(127)(128)(129)(130)(131)(132)(133)(134)(135) pode ser obtida em casos selecionados, especialmente em idosos motivados, com < 80 anos, apresentando ótima tolerabilidade ao tratamento; 7: limites mais elevados em caso de sobrevida limitada e ausência de sintomas. A redução da PA deve ser gradual; 8: PAD = evitar < 65-70 mmHg em portadores de DAC clinicamente manifesta.Diretrizes Brasileiras de Hipertensão Arterial -2020 Barroso et al Arq Bras Cardiol.…”
unclassified
“…Flow-mediated dilation (FMD) of the brachial artery is an indirect non-invasive technique to assess endothelial function and is chie y dependent on NO availability (11). Since acute post-exercise changes in vascular function may also predict long-term adaptations (12) the acute response to exercise has been widely studied (3,13).…”
Section: Introductionmentioning
confidence: 99%